Aquinas of the Week — Summa Theologiae I-II, q. 2, a. 1

Notice first that Aquinas argues against himself before he answers. His opening objection is Scripture: "All things obey money" (Ecclesiastes 10:19). His second is Aristotle — money was invented "that it might be a sort of guarantee for the acquisition of whatever man desires." His third is the plain observation that the appetite for money appears infinite, and the last end must be infinite, so perhaps that is what it is.

Those are the strongest arguments available, and he states them at full strength before laying a finger on them.

Then he divides. Wealth, he writes, is twofold — natural and artificial. Natural wealth "serves man as a remedy for his natural wants: such as food, drink, clothing… and such like." Artificial wealth "is not a direct help to nature, as money, but is invented by the art of man, for the convenience of exchange, and as a measure of things salable."

Sit with that last clause. A measure of things salable. That is money's competence, stated with precision — not a complaint about it, a definition of it. Money can measure anything that can be sold. That is what it is for. It is very good at it.

And then the chain: artificial wealth "is not sought save for the sake of natural wealth" — money is wanted for what it buys. And natural wealth is itself "sought for the sake of something else," since food and clothing serve the man, not the reverse. Each link points past itself. Nothing in the chain can be the last thing, because every item in it is held for the sake of the next.

Hence: "It is impossible for man's happiness to consist in wealth."

Not unwise. Not unbecoming. Impossible — a structural claim, not a moral scolding.

Friday of the Eighteenth Week in Ordinary Time

Gospel: "What profit would there be for one to gain the whole world and forfeit his life? Or what can one give in exchange for his life?" — Matthew 16:26

→ Now put the two together, and the Gospel's question becomes sharper than it first sounds.

Money is a measure of things salable. Christ asks for the exchange rate on a soul. The reason no figure can be named is not that the number would be very large. It is that the soul is not in the set. It is not among things salable, so the instrument that measures salable things has nothing to say about it — the way a scale has nothing to say about the color of what you put on it.

There is no bad exchange rate here. There is no exchange rate. The question is unanswerable by construction, and that unanswerability is the answer.

Which is why the first half of the verse is the trap it is. Gain the whole world — the whole of it, every salable thing there is — and you have still bought nothing on the other side of the line, because everything you gained was on this side. The trade is not merely bad. It does not clear.

The first reading puts the same thing in a harder register. Nahum watches Nineveh, the richest and most fortified city of its world, come down: "Woe to the bloody city, all lies, full of plunder, whose looting never stops!" And then, from a distance, the epitaph — "Nineveh is destroyed; who can pity her? Where can one find any to console her?" Everything Nineveh accumulated was salable. None of it was consolation.

A note: the calendar today also carries two optional memorials — St. Cajetan, Priest, and St. Sixtus II, Pope and Martyr, and his Companions.

Mass readings: bible.usccb.org/bible/readings/080726.cfm

Full market universe · 13 names qualified · system ACTIVE

Two breakouts today. Paysign broke its 52-week pivot on a 467% volume surge — by far the sharpest signal of the week — with the earnings-growth gate confirmed against filed results. Okeanis Eco Tankers broke out alongside it on a more modest 63% surge.

Aquinas's line from the top of this issue is the exact charter of a values screen: a price measures things salable, and the discipline is knowing where that set ends. Gate Zero runs BEFORE any price data is fetched, which is the same claim in software — some things are not evaluated on expected return, because return is the wrong instrument for them.

Behind the two breakouts at the pivot: Revolution Medicines at 99.0 relative strength, Preformed Line Products at 96.3, SAIHEAT at 96.1, Enova International at 94.2, Anika Therapeutics at 94.1. Twenty-four names that otherwise qualified were set aside for reporting earnings this week. Of the thirteen that remain, seven carry an earnings check confirmed against filed results and six do not, labeled rather than assumed.

→ Zero management fee. 20% performance only. 10% of that tithed.

Enoch Capital LLC  ·  2121 S. Broadway, #511, Denver CO 80210
Catholic Daily is an educational publication. It is not investment advice. References to markets, specific securities, or economic conditions are illustrative only and do not constitute recommendations to buy or sell any security. Past performance does not guarantee future results.

Enoch Capital LLC operates under the Publisher's Exemption from the Investment Advisers Act of 1940 (Lowe v. SEC, 472 U.S. 181, 1985). Nothing on this site constitutes the rendering of personalized investment advice. Enoch Capital LLC is not a registered investment adviser.